Moreover, studies documented elevated CXCL13 serum levels in HCC patients, which correlate with tumor size, metastatic disease, advanced stages, and Alanine Transaminase/Aspartate Aminotransferase serum levels (118, 119). Here, CXCL13 is linked to metastatic neoplasm.